Abstract:BackgroundThe use of a transgenic pig for xenotransplantation and as a cardiovascular disease model has caught much attention in the past decades. The vascular endothelial cell is the primary modification target for the application of genetically modified pigs in this field. However, the powerful porcine endothelial cell-specific promoter is still so rare that the mouse and human promoters are commonly used. In the study, the porcine Tie1 (sTie1) promoter was identified and characterized as a potential endothelial cell-specific promoter to generate a cardiovascular disease model.MethodsTie1 promoters with different lengths of 5-regulatory regions were cloned, and major putative DNA-binding motifs were mutated by site-directed mutagenesis. All fragments were ligated into the luciferase reporter system and were transiently transfected into endothelial cells to identify luciferase activity using a dual luciferase reporter assay.ResultsThe luciferase activities of sTie1 promoters with different lengths of the 5-regulatory region were tested. Results showed that the luciferase activity of the 1234-bp sTie1 fragment was the strongest compared with that of others (P<0.001). Site-directed mutagenesis in transcription-factor-binding sites, including Ets, GATA, and AP2, verified their key roles in regulating transcription, especially sites Ets (-103), GATA (-211), and AP2 (-3). The activities of Tie1 promoters from pig, human, and mouse were significantly different in pig iliac endothelial cells (PIECs) (P<0.001), and the sTie1 promoter showed the highest activity. Moreover, sTie1 promoter activity could be detected in porcine embryo fibroblasts and skeletal muscle cells.ConclusionsThe sTie1 promoter shows a highly conserved sequence compared with the Tie1 promoters in human and mouse, but it has a greater activity in the porcine endothelial cell line than that of human and mouse promoters. Thus, sTie1 will be a valuable tool for generating a pig cardiovascular disease model.

Rosa26 locus supports tissue-specific promoter driving transgene expression specifically in pig.

A transgenic Marc-145 cell line of piggyBac transposon-derived targeting shRNA interference against porcine reproductive and respiratory syndrome virus.

Rosa26 -targeted swine models for stable gene over-expression and Cre-mediated lineage tracing

Optimization of a CRISPR/Cas9-mediated Knock-in Strategy at the Porcine Rosa26 Locus in Porcine Foetal Fibroblasts

Validation of Reliable Safe Harbor Locus for Efficient Porcine Transgenesis

Construction of a Porcine Skeletal Muscle-Specific Promoter by Inducing the Seed Region of Mir-208A

PiggyBac Transposon Mediated Efficient Egfp Expression in Porcine Somatic Cells and Cloned Embryos

Production of a Reporter Transgenic Pig for Monitoring Cre Recombinase Activity.

Identification And Characterization Of A Novel Porcine Endothelial Cell-Specific Tie1 Promoter

Generation and characterization of a transgenic pig carrying a DsRed-monomer reporter gene

Establishment of CRISPR/Cas9-Mediated Knock-in System for Porcine Cells with High Efficiency

CRISPR/Cas9-Mediated Specific Integration of Fat-1 and IGF-1 at the p Rosa26 Locus

Identification of the CKM Gene as a Potential Muscle-Specific Safe Harbor Locus in Pig Genome

Site-Specific Fat-1 Knock-In Enables Significant Decrease of n-6PUFAs/n-3PUFAs Ratio in Pigs

Double knock-in pig models with elements of binary Tet-On and phiC31 integrase systems for controllable and switchable gene expression

CRISPR/Cas9-Mediated Specific Integration of Fat-1 and IGF-1 at the Prosa26 Locus

Identification of the <i>CKM</i> Gene as a Potential Muscle-Specific Safe Harbor Locus in Pig Genome

Comparative Study on the Expression Characteristics of Transgenes Inserted into the Gt(ROSA)26Sor and H11 Loci in Mice.

CRISPR/Cas9-mediated Integration of Large Transgene into Pig Potential Safe Harbor

Efficient Generation of Myostatin Mutations in Pigs Using the CRISPR/Cas9 System

Generation of Marker-Free pbd-2 Knock-in Pigs Using the CRISPR/Cas9 and Cre/loxP Systems